RephImmune

Startup

We are a pioneering cell and gene therapy company focused on a revolutionary engineered T cell therapy for solid tumors. Our approach offers the benefits of engineered cell therapy, bypassing the limitations of traditional CAR-T treatments. Our potent immune cells ensure unparalleled efficacy, leading to exceptional tumor eradication. Innovation propels us, redefining the future of cell therapy for solid tumors.

website